Akero Therapeutics (AKRO US)

Analysis

Health Care • United States

Akero Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops medicines and therapies for metabolic diseases by restoring metabolic balance. Akero Therapeutics serves patients and customers in the States of Massachusetts and California.

Refresh

Company Presentation • 11 Jan 2022 23:30

JPMorgan 40th Annual Healthcare Conference

Company Presentation • 11 May 2022 23:40

Bank of America 2022 Healthcare Conference

Company Presentation • 11 Jan 2023 02:30

41st Annual J.P. Morgan Healthcare Conference

Company Presentation • 15 Jan 2025 03:15

43rd Annual J.P. Morgan Healthcare Conference 2025

Company Presentation • 23 Mar 2021 04:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

JPMorgan 40th Annual Healthcare Conference

Bank of America 2022 Healthcare Conference

41st Annual J.P. Morgan Healthcare Conference

43rd Annual J.P. Morgan Healthcare Conference 2025

Study Result